Dermatology clinical trials recruiting in Florida

58 recruiting dermatology trials match in Florida. Showing 20.

• A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)Recruiting

  Phase 1 · UCB Biopharma SRL · South Miami, Florida

• A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe EczemaRecruiting

  Phase 3 · Pfizer · St. Petersburg, Florida

• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)Recruiting

  Phase 4 · Eli Lilly and Company · Hialeah, Florida

• A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisRecruiting

  Phase 3 · Takeda · Hialeah, Florida

• A Study of LY4005130 in Adult Participants With Non-Segmental VitiligoRecruiting

  Phase 2 · Eli Lilly and Company · Miami, Florida

• Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild AcneRecruiting

  Phase 1 / Phase 2 · Sanofi Pasteur, a Sanofi Company · Brandon, Florida

• A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 3 · Nektar Therapeutics · Tamarac, Florida

• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic DermatitisRecruiting

  Phase 3 · AbbVie · Coral Gables, Florida

• A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With VitiligoRecruiting

  Phase 1 · Teva Branded Pharmaceutical Products R&D LLC · Hot Springs, Arkansas

• A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque PsoriasisRecruiting

  Phase 2 · InventisBio Co., Ltd · Birmingham, Alabama

• An Open-Label Extension Study of ORKA-001 in Participants With Plaque PsoriasisRecruiting

  Phase 2 · Oruka Therapeutics, Inc. · Miami, Florida

• A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic DermatitisRecruiting

  Phase 2 · Hoffmann-La Roche · Minneapolis, Minnesota

• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar PustulosisRecruiting

  Phase 3 · UCB Biopharma SRL · Miami, Florida

• Study to Assess Safety, Pharmacokinetics, and Treatment Effect of CabtreoRecruiting

  Phase 4 · Bausch Health Americas, Inc. · North Miami Beach, Florida

• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisRecruiting

  Phase 2 · Apollo Therapeutics Ltd · Cape Coral, Florida

• A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabRecruiting

  Phase 3 · AbbVie · Hollywood, Florida

• Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Recruiting

  Phase 2 · Merck Sharp & Dohme LLC · Aventura, Florida

• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)Recruiting

  Phase 3 · Bristol-Myers Squibb · Boca Raton, Florida

• Phase 3 Study of Denifanstat in Participants With Moderate to Severe AcneRecruiting

  Phase 3 · Sagimet Biosciences Inc. · Doral, Florida

• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic DermatitisRecruiting

  Phase 2 · Apogee Therapeutics, Inc. · Coral Gables, Florida

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.